期刊文献+

结肠腺瘤与腺癌Fas,FasL蛋白的表达及意义 被引量:1

Expressions of Fas/FasL in Colonic Adenoma and Carcinoma and Clinical Significance
暂未订购
导出
摘要 应用免疫组化法检测了30例结肠腺癌与10例结肠腺瘤病例的Fas,FasL蛋白表达。结果显示:结肠癌与腺瘤Fas的阳性表达率差异无显著性(P>0.05),但腺癌组FasL的阳性表达率显著高于腺瘤组。结肠癌组Fas与FasL表达之间,两者同时表达阳性率26.67%;Fas阴性、FasL阳性率为20%。同时表达阴性率30%。Fas阳性、FasL阴性率为23.33%。结肠癌Fas,FasL的阳性表达与其组织学分级、临床分期及淋巴结转移之间无相关关系。提示结肠癌细胞表达Fas或(和)FasL是逃避机体免疫作用的肿瘤生物学特征。 The expressions of Fas/FasL proteins were studied in 10 cases of colon adenoma and 30 colon carcinomas with immunohistochemistry. There was no significant difference between colon adenomas and carcinomas in Fas positive rate (P>0.05). But the positive rate of FasL in colon carcinomas was higher than that in adenomas (P<0.05).These existed multiple and complex relations in the expressions of Fas/FasL.There was no corresponding relationship between positive rates of Fas/FasL in colon carcinoma and its histologic grade,clinic stage and metastases in lymph nodes.The results suggest that the expressions of Fas/FasL in colon carcinoma belong to the neoplasm biologic property,that is,the escape of tumor cells from body immune function.
作者 徐杨 凌奇荷
出处 《湖南医学》 1998年第6期330-332,共3页 Hunan Medical Journal
关键词 结肠肿瘤 腺癌 癌基因蛋白 免疫组织化学 colonic neoplasms oncogene proteins immunohistochemistry
  • 相关文献

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部